Literature DB >> 9168907

Alternative usage of exon 1 of bovine PrP mRNA.

M Horiuchi1, N Ishiguro, H Nagasawa, Y Toyoda, M Shinagawa.   

Abstract

Here we report two types of bovine prion protein (PrP) mRNA that possessed different lengths of the 5'-untranslated region and were expressed in various bovine tissues. The two mRNA species were transcribed from identical positions but differed in the usage of the splice site for exon 1/intron. One mRNA possessed exon 1 consisting of 53 nucleotides and the other possessed exon 1 consisting of 168 nucleotides. Usage of exons 2 and 3 was identical for the two mRNA species. The two mRNA species were detected in all but spleen tissue; the mRNA possessing 168-nt exon 1 was not detected in bovine spleen. This is the first report on the tissue-specific alternative splicing of PrPc mRNA in any other species. Only a low level of PrPc appeared to be present in bovine spleen. These results suggested the possibility that the mRNA possessing 53-nt exon 1 was inefficiently translated into Prp; however, in vitro translation analysis showed no marked difference in translational efficiency between the two mRNA species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168907     DOI: 10.1006/bbrc.1997.6511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice.

Authors:  C Lemaire-Vieille; T Schulze; V Podevin-Dimster; J Follet; Y Bailly; F Blanquet-Grossard; J P Decavel; E Heinen; J Y Cesbron
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  PrPSc-Specific Antibody Reveals C-Terminal Conformational Differences between Prion Strains.

Authors:  Eri Saijo; Andrew G Hughson; Gregory J Raymond; Akio Suzuki; Motohiro Horiuchi; Byron Caughey
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.